What is the latest BI stock price?
The latest stored price for BI is Rs 79.17 as of 2026-11-03.
gimli
BI stock AI analysis
BI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
BILCARE LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available BI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹79.17
1W return
-4.18%
1M return
-18.13%
3M return
+28.04%
6M return
+32.50%
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
36.39
Turnover
₹0.11 cr
Why it can matter in screens
- Momentum: BI is below 50DMA, below 200DMA; RSI is 36.39.
- Returns: 1D +0.11%, 1W -4.18%, 1M -18.13%, 3M +28.04%, 1Y n/a.
- Trend levels: 52W high ₹113.00, 52W low ₹55.00, off high -29.94%.
- Liquidity: latest turnover is ₹0.11 cr; volume vs 20D is +1.42%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR -58.00%, 3Y profit CAGR n/a.
Quick Answers
Is BI above its 50DMA and 200DMA?
BI is below 50DMA, below 200DMA. The latest 50DMA is 92.71 and the latest 200DMA is n/a.
What are BI PE, ROE and ROCE?
BI has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has BI performed recently?
BI has returned -18.13% over 1 month, +28.04% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 225.86 cr | 37.03 cr | 12.70 cr | 5.39 |
| 2026-03-31 | 5.02 cr | -4.16 cr | -6.35 cr | 5.68 |
| 2025-12-31 | 7.27 cr | 3.80 cr | 2.71 cr | -2.53 |
| 2025-09-30 | 5.30 cr | 2.09 cr | 1.04 cr | -5.25 |
| 2025-06-30 | 186.36 cr | 17.15 cr | -3.73 cr | 1.34 |
| 2025-03-31 | 194.03 cr | 28.84 cr | 17.58 cr | n/a |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 32.96 cr | 12.17 cr | 4.00 cr | 1.70 |
| 2024-03-31 | 26.18 cr | 10.34 cr | 5.34 cr | 2.27 |
| 2023-03-31 | 17.71 cr | 507.89 cr | 390.79 cr | 165.97 |
| 2022-03-31 | 445.29 cr | 79.29 cr | -17.78 cr | -7.55 |
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze BILCARE. with valuation, momentum and industry peers
- Compare BI with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare BI with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.